Emergent BioSolutions

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services.

CEO

Joseph C. Papa

CEOJoseph C. Papa

Employees

900

Employees900

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1998

Founded1998

Employees

900

Employees900

EBS Key Statistics

Market cap

417.21M

Market cap417.21M

Price-Earnings ratio

3.26

Price-Earnings ratio3.26

Dividend yield

—

Dividend yield—

Average volume

965.87K

Average volume965.87K

High today

$8.02

High today$8.02

Low today

$7.80

Low today$7.80

Open price

$7.99

Open price$7.99

Volume

466.62K

Volume466.62K

52 Week high

$12.73

52 Week high$12.73

52 Week low

$4.02

52 Week low$4.02

EBS News

Seeking Alpha 1d

Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA

Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA Sep. 15, 2025 8:54 AM ET Emergent BioSolutions Inc. (EBS) Stock By: Harsh S...

TipRanks 5d

Emergent BioSolutions Secures $56 Million Contract Modification

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 6d

Emergent BioSolutions: Strategic Positioning and Contract Wins Support Buy Rating Despite Risks

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions, with a price target of $15.00. Elevate Your Inv...

People also own

Based on the portfolios of people who own EBS. This list is generated using Robinhood data, and it’s not a recommendation.